Celgene Corp. (CELG)

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

Annual Data

Quarterly Data

Celgene Corp., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Short-term borrowings and current portion of long-term debt
Accounts payable
Rebates, distributor chargebacks and distributor services
Compensation
Clinical trial costs and grants
Litigation-related loss contingency
Interest
Sales, use, value added, and other taxes
Contingent consideration
Milestones payable
Deferred tax liability
Other
Accrued expenses and other current liabilities	%	%	%	%	%
Income taxes payable
Current portion of deferred revenue
Current liabilities	%	%	%	%	%
Deferred revenue, net of current portion
Income taxes payable
Deferred income tax liabilities
Other non-current tax liabilities
Contingent consideration
Deferred compensation and long-term incentives
Contingent value rights
Derivative contracts
Other
Other non-current liabilities	%	%	%	%	%
Long-term debt, net of discount, excluding current portion
Non-current liabilities	%	%	%	%	%
Total liabilities	%	%	%	%	%
Preferred stock, $.01 par value per share; none outstanding
Common stock, $.01 par value per share
Common stock in treasury, at cost
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Stockholders' equity	%	%	%	%	%
Total liabilities and stockholders' equity	%	%	%	%	%

	Celgene Corp.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality